RMR Wealth Builders’s Zomedica Corp. ZOM Stock Holding History

RMR Wealth Builders’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-350	Closed	-$1K	–	791
2021 Q1	$1K	Buy	+350	New	+$572	﹤0.01%	780

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

RMR Wealth Builders's ZOM Position: Q2 2021 in Review

RMR Wealth Builders sold out of Zomedica Corp. (ZOM) in Q2 2021, closing a stake of 350 shares — an estimated $1K sold.

RMR Wealth Builders first reported a position in ZOM in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

RMR Wealth Builders reported no remaining Zomedica Corp. position as of Q2 2021 after selling out during the quarter.
RMR Wealth Builders sold 350 Zomedica Corp. shares in Q2 2021, an estimated $1K.
RMR Wealth Builders first reported a position in Zomedica Corp. in Q1 2021 and held it in 1 quarter.
RMR Wealth Builders's Zomedica Corp. position peaked at $1K in Q1 2021.
106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.